Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women

被引:176
|
作者
Szych, C
Staebler, A
Connolly, DC
Wu, R
Cho, KR
Ronnett, BM
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 1999年 / 154卷 / 06期
关键词
D O I
10.1016/S0002-9440(10)65442-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Pseudomyxoma peritonei (PMP) is a poorly understood condition characterized by mucinous ascites and multifocal peritoneal mucinous tumors, Women with PMP often have mucinous tumors involving both the appendix and the ovaries. Several previous histopathological and immunohistochemical studies of PMP have suggested that most, if not all, cases of PMP in women are derived from mucinous adenomas of the appendix rather than from primary ovarian tumors. A few studies of the molecular genetics of PMP have been recently reported. However, these studies analyzed only a small number of cases and some included a heterogeneous group of mucinous tumors, including both benign and malignant appendiceal and ovarian tumors. We analyzed K-ras mutations and allelic losses of chromosomes 18q, 17p, 5q, and 6q in a substantial number of morphologically uniform cases of PMP with synchronous ovarian and appendiceal tumors as well as in appendiceal mucinous adenomas (MAs) and ovarian mucinous tumors of low malignant potential (MLMPs) unassociated with PIMP. Each of the 16 PMP cases (100%) analyzed demonstrated identical K-ras mutations in the appendiceal adenoma and corresponding synchronous ovarian tumor. K-ras mutations were identified in 11 of 16 (69%) appendiceal MAs unassociated with PMP and in 12 of 16 (75%) ovarian MLMPs unassociated with PMP. Two PMP cases showed identical allelic losses in the matched ovarian and appendiceal tumors. A discordant pattern of allelic loss between the ovarian and appendiceal tumors at one or two of the loci tested was observed in six PMP cases. In all but one instance, LOH was observed in the ovarian tumor, whereas both alleles were retained in the matched appendiceal lesion, suggesting tumor progression in a secondary (metastatic) site. Our findings strongly support the conclusion that mucinous tumors involving the appendix acid ovaries in women with PMP are clonal and derived from a single site, most Likely the appendix.
引用
收藏
页码:1849 / 1855
页数:7
相关论文
共 50 条
  • [41] PSEUDOMYXOMA PERITONEI OF THE APPENDICEAL ORIGIN: THE ROLE OF FLUORESCENTAL LAPAROSCOPY AND INTRAPERITONEAL PHOTODYNAMIC THERAPY IN THE COMBINATION WITH CYTOREDUCTIVE SURGERY
    Petrov, L. O.
    Chissov, V. I.
    Sokolov, V. V.
    Belous, T. A.
    Filonenko, E. V.
    Butenko, A. V.
    Sidorov, D. V.
    Grishin, N. A.
    Lozhkin, M. V.
    ANNALS OF ONCOLOGY, 2010, 21 : I40 - I40
  • [42] Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin
    Ghelardi, Filippo
    Raimondi, Alessandra
    Morano, Federica
    Randon, Giovanni
    Pannone, Alessandra
    Guaglio, Marcello
    Mazzoli, Giacomo
    Nasca, Vincenzo
    Milione, Massimo
    Leoncini, Giuseppe
    Sabella, Giovanna
    Greco, Gabriella Francesca
    Lampis, Bianca Rosa
    Galassi, Margherita
    Delfanti, Sara
    Nannini, Margherita
    Intini, Rossana
    Baratti, Dario
    Di Bartolomeo, Maria
    Deraco, Marcello
    Pietrantonio, Filippo
    CLINICAL COLORECTAL CANCER, 2023, 22 (04) : 450 - +
  • [43] Prognosis for Young Females with Pseudomyxoma Peritonei of Appendiceal Origin and Unilateral or Bilateral Ovaries Preserved During Cytoreductive Surgery
    Fu, Fengxian
    Tang, Huangdong
    Lu, Yiyan
    Lu, Dongmei
    Ma, Ruiqing
    FRONTIERS IN SURGERY, 2022, 9
  • [44] Pseudomyxoma peritonei of appendiceal origin: A clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review
    Bradley, RF
    Stewart, JH
    Russell, GB
    Levine, EA
    Geisinger, KR
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (05) : 551 - 559
  • [45] Pseudomyxoma Peritonei: A Case Report of a 62-Year-Old Female With Unexplained Abdominal Enlargement and Appendiceal Origin
    Mohfouz, Ahmed
    Hamed, Manar
    Patel, Anshul
    Tasnim, Shams
    Shah, Princy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [46] Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study
    Alberto Di Leo
    Arianna Corvasce
    Jacopo Weindelmayer
    Elena Jane Mason
    Francesco Casella
    Giovanni de Manzoni
    Updates in Surgery, 2020, 72 : 1207 - 1212
  • [47] Operative Findings, Early Complications, and Long-Term Survival in 456 Patients With Pseudomyxoma Peritonei Syndrome of Appendiceal Origin
    Youssef, Haney
    Newman, Christopher
    Chandrakumaran, Kandiah
    Mohamed, Faheez
    Cecil, Tom D.
    Moran, Brendan J.
    DISEASES OF THE COLON & RECTUM, 2011, 54 (03) : 293 - 299
  • [48] Bland–Altman agreement analysis between CT predicted and surgical peritoneal cancer index in pseudomyxoma peritonei of appendiceal origin
    Mingjian Bai
    Jingliang Chen
    Yueming Xu
    Jing Feng
    Ruiqing Ma
    Hongmin Jia
    Hongbin Xu
    Guowei Liang
    Hongjiang Wei
    Scientific Reports, 13
  • [49] Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study
    Di Leo, Alberto
    Corvasce, Arianna
    Weindelmayer, Jacopo
    Mason, Elena Jane
    Casella, Francesco
    de Manzoni, Giovanni
    UPDATES IN SURGERY, 2020, 72 (04) : 1207 - 1212
  • [50] Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Iavazzo, Christos
    Spiliotis, John
    UPDATES IN SURGERY, 2020, 72 (03) : 923 - 924